Travere Therapeutics director Gary A. Lyons disposes of USD 629,150 in common shares
TVTX•Director sells shares after option exercises
- Travere Therapeutics director Gary A. Lyons sold 10,000 shares on Aug. 17-18 at about $62.53-$64.16.
- The sales followed option exercises for 10,000 shares at $17.44.
- Lyons ended with 61,500 shares of common stock.
